These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26206710)

  • 1. Cortical thickness differences in the prefrontal cortex in children and adolescents with ADHD in relation to dopamine transporter (DAT1) genotype.
    Fernández-Jaén A; López-Martín S; Albert J; Fernández-Mayoralas DM; Fernández-Perrone AL; de La Peña MJ; Calleja-Pérez B; Rodríguez MR; López-Arribas S; Muñoz-Jareño N
    Psychiatry Res; 2015 Sep; 233(3):409-17. PubMed ID: 26206710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cingulate Cortical Thickness and Dopamine Transporter ( DAT1) Genotype in Children and Adolescents With ADHD.
    Fernández-Jaén A; Albert J; Fernández-Mayoralas DM; López-Martín S; Fernández-Perrone AL; Jimenez de la Peña M; Calleja-Pérez B; Recio Rodríguez M; López Arribas S
    J Atten Disord; 2018 May; 22(7):651-660. PubMed ID: 27160695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.
    Bédard AC; Schulz KP; Cook EH; Fan J; Clerkin SM; Ivanov I; Halperin JM; Newcorn JH
    Neuroimage; 2010 Nov; 53(3):935-42. PubMed ID: 20026227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the dopamine transporter gene on neuroimaging findings in different attention deficit hyperactivity disorder presentations.
    Bacanlı A; Unsel-Bolat G; Suren S; Yazıcı KU; Callı C; Aygunes Jafari D; Kosova B; Rohde LA; Ercan ES
    Brain Imaging Behav; 2021 Apr; 15(2):1103-1114. PubMed ID: 33469789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P; Gornick M; Lerch J; Addington A; Seal J; Greenstein D; Sharp W; Evans A; Giedd JN; Castellanos FX; Rapoport JL
    Arch Gen Psychiatry; 2007 Aug; 64(8):921-31. PubMed ID: 17679637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN; Ünal GA; Güler H; Albuz B; Kıroğlu Y; Erdal ME; Herken H
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1373-8. PubMed ID: 27097961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.
    Durston S; Fossella JA; Mulder MJ; Casey BJ; Ziermans TB; Vessaz MN; VAN Engeland H
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):61-67. PubMed ID: 18174826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD.
    Rommelse NN; Altink ME; Arias-Vásquez A; Buschgens CJ; Fliers E; Faraone SV; Buitelaar JK; Sergeant JA; Franke B; Oosterlaan J
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1536-46. PubMed ID: 18729135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter genotype modulates brain activity during a working memory task in children with ADHD.
    Pineau G; Villemonteix T; Slama H; Kavec M; Balériaux D; Metens T; Baijot S; Mary A; Ramoz N; Gorwood P; Peigneux P; Massat I
    Res Dev Disabil; 2019 Sep; 92():103430. PubMed ID: 31306870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls.
    Shook D; Brady C; Lee PS; Kenealy L; Murphy ER; Gaillard WD; VanMeter JW; Cook EH; Stein M; Vaidya CJ
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jan; 156B(1):28-35. PubMed ID: 20957668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD.
    Braet W; Johnson KA; Tobin CT; Acheson R; McDonnell C; Hawi Z; Barry E; Mulligan A; Gill M; Bellgrove MA; Robertson IH; Garavan H
    Neuropsychologia; 2011 Jun; 49(7):1641-50. PubMed ID: 21232548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional effects of the DAT1 polymorphism on EEG measures in ADHD.
    Loo SK; Specter E; Smolen A; Hopfer C; Teale PD; Reite ML
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):986-93. PubMed ID: 12874502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children.
    Hong JH; Hwang IW; Lim MH; Kwon HJ; Jin HJ
    Genes Genomics; 2018 Dec; 40(12):1309-1317. PubMed ID: 30099719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
    Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
    Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.